Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma

Open access

Abstract

RNA-seq is a powerful tool for comprehensive characterization of whole transcriptome at both gene and exon levels and with a unique ability of identifying novel splicing variants. To date, RNA-seq analysis of HBV-related hepatocellular carcinoma (HCC) has not been reported. In this study, we performed transcriptome analyses for 10 matched pairs of cancer and non-cancerous tissues from HCC patients on Solexa/Illumina GAII platform. On average, about 21.6 million sequencing reads and 10.6 million aligned reads were obtained for samples sequenced on each lane, which was able to identify >50% of all the annotated genes for each sample. Furthermore, we identified 1,378 significantly differently expressed genes (DEGs) and 24, 338 differentially expressed exons (DEEs). Comprehensive function analyses indicated that cell growth-related, metabolism-related and immune-related pathways were most significantly enriched by DEGs, pointing to a complex mechanism for HCC carcinogenesis. Positional gene enrichment analysis showed that DEGs were most significantly enriched at chromosome 8q21.3-24.3. The most interesting findings were from the analysis at exon levels where we characterized three major patterns of expression changes between gene and exon levels, implying a much complex landscape of transcript-specific differential expressions in HCC. Finally, we identified a novel highly up-regulated exon-exon junction in ATAD2 gene in HCC tissues. Overall, to our best knowledge, our study represents the most comprehensive characterization of HBV-related HCC transcriptome including exon level expression changes and novel splicing variants, which illustrated the power of RNA-seq and provided important clues for understanding the molecular mechanisms of HCC pathogenesis at system-wide levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0026168

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Assessment of sequencing depth required for transcriptome analysis. (A) Gene coverage of three sequential runs for sample A39P and A39C. (B) Gene coverage for 13 different bin size of million reads randomly chosen from the total sequenced reads of sample A39P or A39C.
Figure 1 Assessment of sequencing depth required for transcriptome analysis. (A) Gene coverage of three sequential runs for sample A39P and A39C. (B) Gene coverage for 13 different bin size of million reads randomly chosen from the total sequenced reads of sample A39P or A39C.CC BY · PubMed Central
Figure 2 Correlation analysis of log2-transformed gene expression level between RNA-seq data and public microarray data (GSE22058) in (A) pooled tumor tissues and (B) non-tumor tissues. Red line stands for the best fit line, and the black line stands for the 45 degree reference line.
Figure 2 Correlation analysis of log2-transformed gene expression level between RNA-seq data and public microarray data (GSE22058) in (A) pooled tumor tissues and (B) non-tumor tissues. Red line stands for the best fit line, and the black line stands for the 45 degree reference line.CC BY · PubMed Central
Figure 3 The distribution of differentially expressed genes in MA plot (A) and their validation by qRT-PCR (B). Fold change (T/NT) of the expression level for a given gene was defined as the read counts of the gene in the tumor sample (T)/the read counts in the non-tumor sample (NT); Concentration for a given gene was defined as the read counts of gene/the total read counts in HCC sample+the read counts of the gene/the total read counts in non-cancerous samples. Each dot represents a gene. Yellow dots represent the genes with no counts in either HCC tumor or non-cancerous tissues. Red dots represent the genes with significantly differential expression. Red rings represent those samples also used for RNA-seq analysis.
Figure 3 The distribution of differentially expressed genes in MA plot (A) and their validation by qRT-PCR (B). Fold change (T/NT) of the expression level for a given gene was defined as the read counts of the gene in the tumor sample (T)/the read counts in the non-tumor sample (NT); Concentration for a given gene was defined as the read counts of gene/the total read counts in HCC sample+the read counts of the gene/the total read counts in non-cancerous samples. Each dot represents a gene. Yellow dots represent the genes with no counts in either HCC tumor or non-cancerous tissues. Red dots represent the genes with significantly differential expression. Red rings represent those samples also used for RNA-seq analysis.CC BY · PubMed Central
Figure 4 Functional annotation of DEG. (A) Analysis of homogeneity for HCC and adjacent non-cancerous tissues using PCC values. The PCC values of gene expression between different samples were represented by different colors: bigger value corresponding to darker color. AVE: Average raw reads number for each gene from re-sequenced sample. The character C represents cancerous tissue sample and P for peri-cancerous tissue sample. (B) Enrichment regions of up-regulated genes on Chromosome 8. (C)Top 10 bio-function terms enriched by DEGs and (D) top 10 canonical pathways enriched by DEGs. Percentage represents the ratio of the number of mapped genes to all genes in a pathway from IPA. Threshold was set (P<0.05 or −log (p)>1.3) by Fisher's Exact Test.
Figure 4 Functional annotation of DEG. (A) Analysis of homogeneity for HCC and adjacent non-cancerous tissues using PCC values. The PCC values of gene expression between different samples were represented by different colors: bigger value corresponding to darker color. AVE: Average raw reads number for each gene from re-sequenced sample. The character C represents cancerous tissue sample and P for peri-cancerous tissue sample. (B) Enrichment regions of up-regulated genes on Chromosome 8. (C)Top 10 bio-function terms enriched by DEGs and (D) top 10 canonical pathways enriched by DEGs. Percentage represents the ratio of the number of mapped genes to all genes in a pathway from IPA. Threshold was set (P<0.05 or −log (p)>1.3) by Fisher's Exact Test.CC BY · PubMed Central
Figure 5 Venn diagram of intersection between 1378 DEGs and 5288 DEE-contained genes.
Figure 5 Venn diagram of intersection between 1378 DEGs and 5288 DEE-contained genes.CC BY · PubMed Central
Figure 6 Analysis and validation of DEEs. (A), (D) and (G): Schematic diagrams of 3 representative genes (CFTR, CCDC50, SIGLEC11) illustrating 3 relationship patterns between DEEs and DEGs. The structure of genes, together with all annotated exons and transcripts, were shown at the bottom. The DEEs were highlighted in red on annotated exons of transcripts showing at the bottom. Red curve represents the normalized read counts for HCC tissues and blue curve represents the normalized read counts for adjacent non-cancerous tissues. (B), (E) and (H): Comparison of expression levels of DEEs in three representative genes between HCC and adjacent non-cancerous tissues. (C), (F) and (I): Comparison of expression ratio for different DEEs of the same representative gene in HCC and adjacent non-cancerous tissues. T: tumor NT: Non-tumor.
Figure 6 Analysis and validation of DEEs. (A), (D) and (G): Schematic diagrams of 3 representative genes (CFTR, CCDC50, SIGLEC11) illustrating 3 relationship patterns between DEEs and DEGs. The structure of genes, together with all annotated exons and transcripts, were shown at the bottom. The DEEs were highlighted in red on annotated exons of transcripts showing at the bottom. Red curve represents the normalized read counts for HCC tissues and blue curve represents the normalized read counts for adjacent non-cancerous tissues. (B), (E) and (H): Comparison of expression levels of DEEs in three representative genes between HCC and adjacent non-cancerous tissues. (C), (F) and (I): Comparison of expression ratio for different DEEs of the same representative gene in HCC and adjacent non-cancerous tissues. T: tumor NT: Non-tumor.CC BY · PubMed Central
Figure 7 Analysis and confirmation of a differently expressed novel exon-exon junction identified for the ATAD2 gene. (A) A schematic diagram of the differently expressed novel junction in ATAD2. Red line represents tumor tissues and blue line represents adjacent non-cancerous tissues. The structure of gene was plotted at the bottom. The connecting lines below exons represent all known annotated junctions. The red connecting line above exons represents the predicted novel exon-exon junction. (B) Relative expression of the novel junction of ATAD2 in HCC and non-cancerous tissues. (C) RT-PCR analysis on agrose gel electrophoresis for the novel junction in HCC and non-cancerous tissues from 2 HCC patients. HPRT1 was used as the internal control. (D) A schematic diagram of amino acid sequence for exon 6–8 in ATAD2 gene.
Figure 7 Analysis and confirmation of a differently expressed novel exon-exon junction identified for the ATAD2 gene. (A) A schematic diagram of the differently expressed novel junction in ATAD2. Red line represents tumor tissues and blue line represents adjacent non-cancerous tissues. The structure of gene was plotted at the bottom. The connecting lines below exons represent all known annotated junctions. The red connecting line above exons represents the predicted novel exon-exon junction. (B) Relative expression of the novel junction of ATAD2 in HCC and non-cancerous tissues. (C) RT-PCR analysis on agrose gel electrophoresis for the novel junction in HCC and non-cancerous tissues from 2 HCC patients. HPRT1 was used as the internal control. (D) A schematic diagram of amino acid sequence for exon 6–8 in ATAD2 gene.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 104

Metadata

Authors
Huang, Q., Lin, B., Liu, H., Ma, X., Mo, F., Yu, W., Li, L., Li, H., Tian, T., Wu, D., Shen, F., Xing, J., & Chen, Z.-N.
Affiliations
  • State Key Laboratory of Cancer Biology (CN)
  • University of Washington (US)
  • Zhejiang University (CN)
  • Beijing Jiaotong University (CN)
  • Second Military Medical University (CN)
Corresponding author
  • Xing, Jinliang
  • Chen, Zhi-Nan
Venue
PLoS ONE
Published
2011-10-17
Volume
6
Issue
10
Pages
e26168
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2088301231
Cited by
104
References
56
Citations by year
2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 10 · 2018: 6 · 2017: 14 · 2016: 6 · 2015: 10 · 2014: 8 · 2013: 16 · 2012: 9
FWCI
4.55
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Natural Science Foundation of China (30872927)
  • National Key Research and Development Program of China (2009CB521704)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
hepatocellular carcinoma, HBV-related liver cancer, transcriptome, differentially expressed genes, splice variants, exon-exon junctions, ATAD2, carcinogenesis, gene expression profiling
MeSH terms
Exons, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, RNA, Messenger, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, Protein Isoforms, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1371/journal.pone.0026168
The paper
Huang, Q., Lin, B., Liu, H., Ma, X., Mo, F., Yu, W., Li, L., Li, H., Tian, T., Wu, D., Shen, F., Xing, J., & Chen, Z.-N. (2011). RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma. PLoS ONE. https://doi.org/10.1371/journal.pone.0026168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.